Status:
UNKNOWN
Fugal Infection in COVID-19 Patients
Lead Sponsor:
Assiut University
Conditions:
Covid19
Eligibility:
All Genders
Brief Summary
Screening early detection of invasive fungal sinusitis in COVID-19 positive patients
Detailed Description
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2); the causative organism of Coronavirus disease 2019 (Covid-19); infects primarily the lungs leading to more than 100 million COVID-19 cases...
Eligibility Criteria
Inclusion
- Patients who were diagnosed with invasive fungal sinusitis, and are survivors of Covid19 infection, all cases diagnosed on the basis of the interim guidance of the World Health Organization (WHO) for diagnosis of SARS-CoV-2.
Exclusion
- \- Patients who received antifungal therapy within three days prior to sample collection.
- Patients refused to participate in the study.
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04914013
Start Date
June 1 2021
End Date
September 1 2021
Last Update
June 4 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.